Drug Discovery Outsourced Market Size Expected to Reach US$56.7 Billion at a CAGR of 12.1% by 2028 | Share analysis, future prospects, growth estimation and industry trends


Outsourced drug discovery is a contractual procedure conducted by contract research organizations (CROs) and contract manufacturing organizations (CMOs) (CMOs). Contract research organizations provide drug discovery and development assistance to the pharmaceutical, biotechnology, and medical device industries. CROs support drug discovery and development services such as biopharmaceutical development, bioassay development, preclinical research, clinical trials, and pharmacovigilance.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2847


The partnership tactics employed by major players in the drug research and development process are expected to drive the global outsourced drug discovery market across the globe. For example, in April 2019, Medicine Discovery Catapult partnered with 22 UK-based contract research groups and launched a virtual R&D discovery services platform staffed by over 20 CROs, which would help small and medium-sized companies to carry out drug discovery projects.

In addition, increased new site launches for the development of clinical research practices are expected to drive global growth. outsourced drug discovery market growth. For example, INC Research Holdings, Inc., a contract research company, formed the industry’s first Site Advocacy Group (SAG) in June 2015 to support the development and advancement of clinical research operations. SAG’s research and development operations focus on schizophrenia, depression and bipolar disease.

Key development:

The major players in the market are focusing on initiating drug development services. For example, in March 2018, Evotec AG announced INDiGO, a new drug discovery service. This service is employed during the drug research and development stages. INDiGO is an integrated drug development technology that helps accelerate drug development processes from candidate screening to NDA filing. It has the potential to shorten and reduce the cost of the drug development process. Also, the introductions of new drug discovery platforms are likely to drive the growth of the global outsourced drug discovery market.

Key players:

The major players active in the global outsourced drug discovery market are Bioduro LLC, Charles River Laboratories (CRL), Shanghai Medicilon, TCG Lifesciences, Chempartner, Syngene International Ltd. Jubilant Biosys Ltd, Evotec AG, Sundia Meditech Co. Ltd, Pharmaron Inc. and Aurigene Accelerating Discovery.

Buy this report with flat discount of 2000 USD @ https://www.coherentmarketinsights.com/promo/buynow/2847


Chapter 1 Industry overview
1.1 Definition
1.2 Assumptions
1.3 Scope of research
1.4 Market Analysis by Regions
1.5 Outsourced Drug Discovery Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Impact on Outsourced Drug Discovery Industry

Chapter 2 Global Outsourced Drug Discovery Competition by Types, Applications and Top Regions and Countries
2.1 Global Outsourced Drug Discovery (Volume and Value) by Type
2.3 Global Outsourced Drug Discovery (Volume and Value) by Regions

chapter 3 Generation market analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Outsourced Drug Discovery Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Outsourced Drug Discovery Market Analysis
Chapter 6 East Asia Outsourced Drug Discovery Market Analysis
Chapter 7 Analysis of the outsourced drug discovery market in Europe
Chapter 8 South Asia Outsourced Drug Discovery Market Analysis
Chapter 9 Southeast Asia Outsourced Drug Discovery Market Analysis
Chapter 10 Middle East Outsourced Drug Discovery Market Analysis
Chapter 11 Market analysis of outsourced drug discovery in Africa
Chapter 12 Oceania Outsourced Drug Discovery Market Analysis
Chapter 13 South America Outsourced Drug Discovery Market Analysis
Chapter 14 Company profiles and key figures of outsourced drug discovery business
Chapter 15 Global Outsourced Drug Discovery Market Forecast (2022-2028)
Chapter 16 conclusion
Research Methodology

Get Sample PDF Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/2847

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We’re known for our actionable insights and genuine reports in a variety of fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insights in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.


Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
E-mail: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Armand Downs

Check Also

Week in Review: Insilico Signs Six AI-Drug Discovery Deal with Sanofi Worth Up to $1.2 Billion

jittawit.21 Offers and financing Insilico Medicine, a Hong Kong and New York-based AI drug discovery …